Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.

Conventional delivery of chemotherapeutic agents leads to multiple systemic side effects and toxicity, limiting the doses that can be used. The development of targeted therapies to selectively deliver anti-cancer agents to tumor cells without damaging neighboring unaffected cells would lead to highe...

Descripción completa

Detalles Bibliográficos
Publicado en:Targeted Oncology Vol. 10; no. 4; pp. 467 - 486
Autores principales: Benedetto, Gregory, Vestal, C., Richardson, Christine, Vestal, C Greer
Formato: review tables/charts Journal Article
Publicado: Springer Nature Dec2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111336595&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 111336595
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17762596
        47DQ
      jtl: Targeted Oncology
      issn: 17762596
      maglogo: N
    pubinfo:
      dt: Dec2015
      vid: 10
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        111336595
        111336595
        NLM25989948
        111336595
        10.1007/s11523-015-0371-z
        NLM25989948
        111336595
      ppf: 467
      ppct: 19
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.
      aug:
        au:
          Benedetto, Gregory
          Vestal, C.
          Richardson, Christine
          Vestal, C Greer
        affil: Department of Biological Sciences, UNC Charlotte, 1902 University City Blvd., Woodward Hall Room 386B Charlotte 28223 USA
      sug:
        subj:
          Antineoplastic Agents Administration and Dosage
          Nanoparticles
          Neoplasms Drug Therapy
          Nucleotides Administration and Dosage
          Neoplasms
          Drug Therapy
          Nucleotides
      ab: Conventional delivery of chemotherapeutic agents leads to multiple systemic side effects and toxicity, limiting the doses that can be used. The development of targeted therapies to selectively deliver anti-cancer agents to tumor cells without damaging neighboring unaffected cells would lead to higher effective local doses and improved response rates. Aptamers are single-stranded oligonucleotides that bind to target molecules with both high affinity and high specificity. The high specificity exhibited by aptamers promotes localization and uptake by specific cell populations, such as tumor cells, and their conjugation to anti-cancer drugs has been explored for targeted therapy. Advancements in the development of polymeric nanoparticles allow anti-cancer drugs to be encapsulated in protective nonreactive shells for controlled drug delivery with reduced toxicity. The conjugation of aptamers to nanoparticle-based therapeutics may further enhance direct targeting and personalized medicine. Here we present how the combinatorial use of aptamer and nanoparticle technologies has the potential to develop "smart bombs" for targeted cancer treatment, highlighting recent pre-clinical studies demonstrating efficacy for the direct targeting to particular tumor cell populations. However, despite these pre-clinical promising results, there has been little progress in moving this technology to the bedside.
      pubtype: Academic Journal
      doctype:
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N